Search Login Register

bivalirudin (Angiomax) Summary

Description: designed to bind to the alpha-thrombin catalytic site and anion-binding exosite for fibrin(ogen) recognition

Also Known As: Angiomax; BG 8967; BG-8967; BG8967; Hirulog Show All >>

Networked: 652 relevant articles (106 outcomes, 211 trials/studies) for this Drug

Key Diseases for which bivalirudin is Relevant

  1. Hemorrhage : 62 outcomes 98 studies in 367 results
  2. Acute Coronary Syndrome : 21 outcomes 45 studies in 115 results
  3. Myocardial Infarction : 18 outcomes 85 studies in 190 results
  4. Thrombosis (Thrombus) : 18 outcomes 21 studies in 137 results
  5. Unstable Angina : 7 outcomes 11 studies in 35 results
Show All >>

Drugs Related to bivalirudin

  1. Heparin (Liquaemin)
  2. Glycoproteins (Glycoprotein)
  3. Thrombin
  4. Platelet Membrane Glycoprotein IIb
  5. clopidogrel (Plavix)
  6. Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
  7. bivalirudin (Angiomax)
  8. Enoxaparin (Lovenox)
  9. Hirudins
  10. Antithrombins
Show All >>

Therapies Related to bivalirudin

  1. Stents
  2. Angioplasty (Angioplasty, Transluminal)
  3. Drug Therapy (Chemotherapy)
  4. Transplants (Transplant)
  5. Coronary Balloon Angioplasty (Percutaneous Transluminal Coronary Angioplasty)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.